Therefore, hyper-FGF23-emia is a clinical phenomenon that requires continuous attention from nephrologists and hemodialysis physicians and may be a key tool for early intervention in achieving improvement in CKD-MBD patients. Here, FGF23 is linked to chronic kidney disease.